Bruker Corporation
BRKR
$37.99
-$0.44-1.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.04% | 14.64% | 16.37% | 17.42% | 5.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.04% | 14.64% | 16.37% | 17.42% | 5.31% |
| Cost of Revenue | 11.90% | 14.50% | 21.93% | 18.07% | 11.34% |
| Gross Profit | 10.18% | 14.78% | 11.17% | 16.77% | -0.14% |
| SG&A Expenses | 15.42% | 17.98% | 28.96% | 24.34% | 20.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 143.75% | -861.11% | 278.13% | 160.00% | -23.81% |
| Total Operating Expenses | 14.17% | 14.53% | 27.14% | 21.62% | 14.70% |
| Operating Income | -13.95% | 15.19% | -34.00% | -10.23% | -36.32% |
| Income Before Tax | -64.48% | -77.41% | -53.89% | -69.50% | -33.08% |
| Income Tax Expenses | -56.06% | 9.70% | -51.95% | -19.10% | -33.78% |
| Earnings from Continuing Operations | -67.69% | -93.21% | -54.57% | -86.85% | -32.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 154.55% | -122.22% | 200.00% | -- | -22.22% |
| Net Income | -65.82% | -93.33% | -53.58% | -86.69% | -33.46% |
| EBIT | -13.95% | 15.19% | -34.00% | -10.23% | -36.32% |
| EBITDA | 3.91% | 20.72% | -12.76% | 8.72% | -23.94% |
| EPS Basic | -67.26% | -93.60% | -55.07% | -86.74% | -32.72% |
| Normalized Basic EPS | -26.48% | 12.74% | -39.31% | -10.60% | -25.62% |
| EPS Diluted | -68.57% | -93.58% | -55.00% | -87.15% | -32.69% |
| Normalized Diluted EPS | -26.26% | 12.82% | -39.22% | -10.41% | -25.57% |
| Average Basic Shares Outstanding | 4.41% | 4.19% | 3.34% | 0.41% | -1.09% |
| Average Diluted Shares Outstanding | 4.11% | 4.11% | 3.19% | 0.20% | -1.15% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 2.09% | 14.62% | 1.21% | 6.92% | 0.48% |